Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Vaxxinova logo — committed to disease prevention

Vaxxinova

committed to disease prevention

Founded 2010 The Netherlands The Netherlands 174 employees Manufacturing, Pharmaceutical

General Information

Company Name Vaxxinova
Founded Year 2010
Location The Netherlands The Netherlands +1
Employees 174
Industries Manufacturing, Pharmaceutical
Social

Get notified when Vaxxinova moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Vaxxinova

Vaxxinova is a company committed to disease prevention, specializing in the development, production, and marketing of innovative vaccines and diagnostic services to protect livestock and fish against diseases. The company's high-quality solutions are aimed at improving animal health and meeting the current and future requirements in animal health. Vaxxinova's strong investment in R&D underscores its belief in innovation and excellence in research as essential elements for producing premium products. The company's network spans 10 countries, including Brazil, Chile, Germany, Italy, Japan, Jordan, Norway, the Netherlands, Thailand, and the USA, with international presence in more than 60 countries. As part of the family-owned EW Group, specialized in animal genetics, nutrition, and animal health, Vaxxinova benefits from a company committed to R&D and consistent international growth. Founded in 2010, Vaxxinova offers a driven, entrepreneurial, and down to earth working environment, with excellent opportunities for professional development, and is currently expanding its organization locally and at the head office. Vaxxinova presents an exciting opportunity for investors in the Manufacturing and Pharmaceutical industries.

Taxonomy: Veterinary vaccines, Animal health, R&D, Livestock, Fish health, Diagnostic services, Global presence, Family-owned company, Private company, International growth, Animal genetics, Nutrition, Entrepreneurial culture, Professional development, Multi-location operations

No funding data available for Vaxxinova yet.

Get notified when Vaxxinova raises funding

Vaxxinova Alternatives & Competitors

Vaxxinova vs
CEVA SANTE ANIMALE
CEVA SANTE ANIMALE France

Together, beyond animal health.

Series Unknown
6316 employees
Biotechnology, Pharmaceutical
Vaxxinova vs
Link My Pet
Link My Pet United States

📍24/7 GPS Tracking 📈 Exercise Monitoring 🔔 Built-In Training & Health Tools 🐾All in one smart c...

10 employees
Information Technology, Manufacturing
Vaxxinova vs
MEVAC for Vaccines
MEVAC for Vaccines Egypt

Science , Innovation , Quality

298 employees
Health Care

FAQ About Vaxxinova

committed to disease prevention
Vaxxinova was founded in 2010.
Vaxxinova is headquartered in The Netherlands.
Vaxxinova operates in the following industries: Manufacturing, Pharmaceutical.
Vaxxinova has approximately 174 employees.
Top alternatives and competitors to Vaxxinova include CEVA SANTE ANIMALE, Link My Pet, MEVAC for Vaccines , Zinpro Corporation, Vimian Group. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Vaxxinova and CEVA SANTE ANIMALE are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Vaxxinova and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy